Cellular Biomedicine Group, Inc. (CBMG): New Bullish Coverage

CBMG – B. Riley FBR, Inc. initiates as a buy, $32PT. This price target represents a 78.77% upside over the stock’s previous closing price of $17.90.

Update: As of Dec. 14, 2018, this bullish analyst call has returned 7.82%.

Key Facts Surrounding This News Item

  • CBMG had a POWR Rating of C (Neutral) coming into today.
  • CBMG was 5.57% above its 10-Day Moving Average coming into today.
  • CBMG was 5.09% above its 20-Day Moving Average coming into today.
  • CBMG was 3.33% above its 50-Day Moving Average coming into today.
  • CBMG was 29.14% above its 100-Day Moving Average coming into today.
  • CBMG was 57.31% above its 200-Day Moving Average coming into today.
  • CBMG had returned +59.11% year-to-date leading up to today’s news, versus a +2.22% return from the benchmark S&P 500 during the same period.

More Info About Cellular Biomedicine Group, Inc. (CBMG)

Cellular Biomedicine Group develops treatments for cancerous and degenerative diseases in China. The company was incorporated in 2001 and is based in Palo Alto, California. View our full CBMG ticker page with ratings, news, and more.

CBMG at a Glance

CBMG Current POWR Rating™
Overall POWR Rating™
CBMG Current Price $19.30 2.13%
More CBMG Ratings, Data, and News

CBMG Price Reaction

The day of this event (Mar. 8, 2018)
CBMG Closing Price$17.75 0.84%
CBMG Volume37,500
12.35% from avg
Leading up to this event
CBMG 1-mo return0.56%
After this event
CBMG 1-day return5.54%
CBMG 3-day return9.37%
CBMG 5-day return6.28%

CBMG Price Chart

The Top Stocks For 2019

More Cellular Biomedicine Group, Inc. (CBMG) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All CBMG News
Page generated in 0.8412 seconds.